IP Library Granted Patent US 12,187,829
Granted Patent B2
US 12,187,829 · App. 17/861,204 · Granted Jan 7, 2025

Environmentally biodegradable microcapsules

Inventors: Jiten Dihora (Center Valley, PA); Stephen Crescimanno (Hatfield, PA)
Assignee: TRUCAPSOL LLC
C08F251/00A61K8/11A61K8/91A61Q5/02A61Q5/12A61Q19/10B01J13/16C11D3/001C11D3/3788C11D3/505A61K2800/624A61K2800/654C11D2111/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,187,829
App. No.
17/861,204
Granted
Jan 7, 2025
Kind
B2
Abstract

Disclosed is a modified biopolymer having the formula A-XY wherein: (a) A is a starting material selected from the group consisting of a polysaccharide, a protein and a cellulose; (b) X is a first moiety bearing a functionality co-reactive with A; (c) Y is a second moiety covalently bound to X, capable of undergoing free radical polymerization and bearing at least two ethylenically unsaturated functional groups; (d) the starting material A and the first moiety X are linked covalently through linkages selected from the group consisting of an ester, an amide, a urethane, a urea, a sulfonate ester, a phosphate ester and an ether; and (e) a degree of substitution of the starting material A with the first moiety X is less than 0.5 but more than 0.1. Compositions including the modified biopolymer and methods for making them are also disclosed.

Claims (30)

1. A modified biopolymer having the formula A-XY wherein:

A is a starting material of a polysaccharide selected from the group consisting of tapioca starch, potato starch, corn starch, rice starch, wheat starch, carboxymethyl starch, carboxymethyl chitosan, chitosan oligosaccharide, and octenyl succinic anhydride modified starch;

X is a first moiety bearing a functionality co-reactive with the starting material A, wherein the first moiety X is selected from the group consisting of t-butyl acetoacetate, t-butyl cyanoacetate, and a Michael adduct of alkyl acetoacetate or alkyl cyanoacetate with ethylenically unsaturated monomer bearing an anhydride functionality, an epoxy functionality, an isocyanate functionality or an oxazoline functionality;

Y is a second moiety covalently bound to the first moiety X, capable of undergoing free radical polymerization and having an acrylate, methacrylate, styrenic, vinyl ester or vinyl ether bearing at least three ethylenically unsaturated groups;

the starting material A and the first moiety X are linked covalently through linkages selected from the group consisting of an ester, an amide, a urethane, a urea, a sulfonate ester, a phosphate ester and an ether; and

a degree of substitution of the starting material A with the first moiety X is less than 0.5 but more than 0.1, and

wherein the modified biopolymer has an Environmental Biodegradability greater than 30% within 28 days according to OECD 301.

2. The modified biopolymer of claim 1 , wherein the starting material A is adjusted to a lower molecular weight before incorporation into the modified biopolymer.

3. A composition comprising controlled release particles, wherein each of the controlled release particles comprises:

at least one hydrophobic active ingredient; and

a reaction product of a free radical polymerization of the modified biopolymer of claim 1 and at least one ethylenically unsaturated monomer.

4. The composition of claim 3 , further comprising at least one member selected from the group consisting of a free radical initiator, a cationic deposition aid, an isocyanate, an epoxy, an organofunctional silane, an epoxide curing agent, a plasticizer and an inorganic solid particle.

5. The composition of claim 3 , wherein the at least one hydrophobic active ingredient is a member selected from the group consisting of a flavorant, a fragrance, a chromogen, a dye, an essential oil, a sweetener, an oil, a pigment, an active pharmaceutical ingredient, a moldicide, a herbicide, a fertilizer, a phase change material, an adhesive, a vitamin oil, a vegetable oil, a triglyceride and a hydrocarbon.

6. The composition of claim 3 , wherein the controlled release particles have a diameter from 0.1 microns to less than 200 microns.

7. The composition of claim 3 , which is a powdered food product, a fluid food product, a powdered nutritional supplement, a fluid nutritional supplement, a fluid fabric enhancer, a solid fabric enhancer, a fluid shampoo, a solid shampoo, a hair conditioner, a body wash, a solid antiperspirant, a fluid antiperspirant, a solid deodorant, a fluid deodorant, a fluid detergent, a solid detergent, a fluid hard surface cleaner, a solid hard surface cleaner, a fluid fabric refresher spray, a diaper, an air freshening product, a nutraceutical supplement, a controlled release fertilizer, a controlled release insecticide, a controlled release dye or a unit dose detergent comprising a detergent and the controlled release particles in a water soluble film.

8. The composition of claim 3 , wherein the composition comprises two different controlled release particles which are friction-triggered release microcapsules which release the at least one hydrophobic active ingredient at different rates due to a difference in shell material friability or core material viscosity.

9. A method of preparing a composition comprising controlled release particles, said method comprising the sequential steps of:

(a) preparing an oil phase, wherein the oil phase comprises:

(i) at least one hydrophobic active ingredient, and at least one ethylenically unsaturated monomer or free radical initiator; or

(ii) at least one hydrophobic active ingredient, at least one ethylenically unsaturated monomer and free radical initiator and optionally one or more compounds selected from the group consisting of: an isocyanate, an epoxy, an organofunctional silane, an epoxide curing agent, a plasticizer and an inorganic solid particle;

(b) preparing an aqueous phase comprising the modified biopolymer according to claim 1 , and optionally an emulsifier, buffer, ionic strength modifier or water soluble free radical initiator;

(c) combining the oil phase and the aqueous phase to emulsify the at least one hydrophobic active ingredient to provide an aqueous suspension of the at least one hydrophobic active ingredient;

(d) heating the aqueous suspension; and

(e) adding structuring agents to the aqueous suspension to provide the controlled release particles homogeneously suspended in an aqueous dispersion.

10. The method of claim 9 , wherein the free radical initiator is a member selected from the group consisting of azo initiators and alkyl peroxides.

11. The method of claim 9 , wherein at least one suspension agent is included in the composition to suspend the controlled release particles, wherein the at least one suspension agent is at least one member selected from the group consisting of a rheology modifier, a structurant and a thickener.

12. The method of claim 11 , wherein the at least one suspension agent has a high shear viscosity at, 20 sec −1 shear rate and at 21° C., of from 1 to 7000 cps and a low shear viscosity, at 0.5 sec −1 shear rate at 21° C., of greater than 1000 cps.

13. The method of claim 11 , wherein a finished capsule slurry is a fluid having a high shear viscosity, at 20 sec −1 and at 21° C., of from 50 to 3000 cps and a low shear viscosity, at 0.5 sec −1 shear rate at 21° C., of greater than 1000 cps.

14. The method of claim 11 , wherein the at least one suspension agent is a member selected from the group consisting of polyacrylates, polymethacrylates, polycarboxylates, pectin, alginate, gum arabic, gelatin, carrageenan, gellan gum, xanthan gum, guar gum, hydroxyl-containing fatty acids, hydroxyl-containing fatty esters, hydroxyl-containing fatty waxes, castor oil, castor oil derivatives, hydrogenated castor oil derivatives, hydrogenated castor wax, perfume oil, and mixtures thereof.

15. A composition comprising the controlled release particles prepared by the method of claim 9 , each of the controlled release particles comprises: at least one hydrophobic active ingredient; and a reaction product of a free radical polymerization of the modified biopolymer of claim 1 and at least one ethylenically unsaturated monomer.

Assignments (2)
SECURITY INTEREST Recorded Sep 25, 2023
From: TRUCAPSOL LLC
To: ALTER DOMUS (US) LLC
Reel/Frame 065010/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2022
From: DIHORA, JITEN; CRESCIMANNO, STEPHEN
To: TRUCAPSOL LLC
Reel/Frame 060467/0586 →
Continuity (2)
Provisional Application 63232458 · Aug 12, 2021
Related Publication 20230060181A1 · Mar 2, 2023
References Cited (120)
US 2573900A · Freeman · 1951 [cited by applicant]
US 3345358A · Inklaar · 1967 [cited by applicant]
US 3819838A · Smith et al. · 1974 [cited by applicant]
US 3870542A · Ida et al. · 1975 [cited by applicant]
US 4076774A · Short · 1978 [cited by applicant]
US 4396670A · Sinclair · 1983 [cited by applicant]
US 4626471A · Chao · 1986 [cited by applicant]
US 4818539A · Shaw et al. · 1989 [cited by applicant]
US 5015527A · Chao · 1991 [cited by applicant]
US 5126151A · Bodor et al. · 1992 [cited by applicant]
US 5227446A · Denzinger et al. · 1993 [cited by applicant]
US 5550189A · Qin et al. · 1996 [cited by applicant]
US 5574179A · Wahl et al. · 1996 [cited by applicant]
US 5601760A · Rosenberg · 1997 [cited by applicant]
US 5837747A · Soon-Shiong et al. · 1998 [cited by applicant]
US 6248909B1 · Akimoto et al. · 2001 [cited by applicant]
US 6465016B2 · Parikh et al. · 2002 [cited by applicant]
US 6572919B2 · Westland et al. · 2003 [cited by applicant]
US 6596073B1 · Nyssen et al. · 2003 [cited by applicant]
US 6855335B2 · Seok et al. · 2005 [cited by applicant]
US 7431986B2 · Van Lengerich et al. · 2008 [cited by applicant]
US 8900495B2 · Pacorel et al. · 2014 [cited by applicant]
US 8993041B2 · To et al. · 2015 [cited by applicant]
US 9205395B2 · Yan · 2015 [cited by applicant]
US 9332774B2 · Nakhasi et al. · 2016 [cited by applicant]
US 9416050B2 · Seidl et al. · 2016 [cited by applicant]
US 9427719B2 · Viaud-Massuard et al. · 2016 [cited by applicant]
US 9714397B2 · Feng et al. · 2017 [cited by applicant]
US 9937477B2 · Zhang et al. · 2018 [cited by applicant]
US 9944886B2 · Hitchcock et al. · 2018 [cited by applicant]
US 9993401B2 · Barnett et al. · 2018 [cited by applicant]
US 10188593B2 · Dihora et al. · 2019 [cited by applicant]
US 11179302B2 · Dardelle · 2021 [cited by applicant]
US 11344502B1 · Dihora et al. · 2022 [cited by applicant]
US 11465117B2 · Bachawala et al. · 2022 [cited by applicant]
US 11484857B2 · Bachawala et al. · 2022 [cited by applicant]
US 11542392B1 · Multari · 2023 [cited by applicant]
US 11547978B2 · Bachawala et al. · 2023 [cited by applicant]
US 11571674B1 · Dihora et al. · 2023 [cited by applicant]
US 20020169233A1 · Schwantes · 2002 [cited by applicant]
US 20040017017A1 · Van Lengerich et al. · 2004 [cited by applicant]
US 20040033264A1 · Sawhney · 2004 [cited by applicant]
US 20050272628A1 · Meli et al. · 2005 [cited by applicant]
US 20050276831A1 · Dihora et al. · 2005 [cited by applicant]
US 20060069234A1 · Kauffman · 2006 [cited by examiner]
US 20070122455A1 · Myers et al. · 2007 [cited by applicant]
US 20080085297A1 · Dave et al. · 2008 [cited by applicant]
US 20080103265A1 · Schocker et al. · 2008 [cited by applicant]
US 20080167188A1 · Fischer et al. · 2008 [cited by applicant]
US 20090209661A1 · Somerville Roberts et al. · 2009 [cited by applicant]
US 20100011610A1 · Bittorf et al. · 2010 [cited by applicant]
US 20100028451A1 · Kaplan et al. · 2010 [cited by applicant]
US 20110052680A1 · Hendrickson et al. · 2011 [cited by applicant]
US 20110268778A1 · Dihora et al. · 2011 [cited by applicant]
US 20110268802A1 · Dihora et al. · 2011 [cited by applicant]
US 20120128752A1 · Loo et al. · 2012 [cited by applicant]
US 20130004617A1 · Zhang et al. · 2013 [cited by applicant]
US 20130022654A1 · Deshmukh et al. · 2013 [cited by applicant]
US 20130084379A1 · Gregson et al. · 2013 [cited by applicant]
US 20130239429A1 · Vella et al. · 2013 [cited by applicant]
US 20140199244A1 · Rijcken et al. · 2014 [cited by applicant]
US 20140335032A1 · Panandiker et al. · 2014 [cited by applicant]
US 20150079139A1 · Takehana · 2015 [cited by applicant]
US 20150252312A1 · De Villeneuve et al. · 2015 [cited by applicant]
US 20160038428A1 · Harel et al. · 2016 [cited by applicant]
US 20160128944A1 · Chawrai et al. · 2016 [cited by applicant]
US 20160158121A1 · Lei et al. · 2016 [cited by applicant]
US 20160166480A1 · Lei et al. · 2016 [cited by applicant]
US 20160206561A1 · Kohane et al. · 2016 [cited by applicant]
US 20160228338A9 · Dihora et al. · 2016 [cited by applicant]
US 20170165627A1 · Duan et al. · 2017 [cited by applicant]
US 20170360676A1 · Dihora · 2017 [cited by examiner]
US 20180015009A1 · Soubiran et al. · 2018 [cited by applicant]
US 20180042825A1 · Lei et al. · 2018 [cited by applicant]
US 20190192444A1 · Barzilay et al. · 2019 [cited by applicant]
US 20190275490A1 · Bachawala · 2019 [cited by applicant]
US 20210045409A1 · Witteveen et al. · 2021 [cited by applicant]
US 20220133603A1 · Bachawala et al. · 2022 [cited by applicant]
US 20220177815A1 · Popplewell · 2022 [cited by examiner]
US 20220408771A1 · Dihora · 2022 [cited by applicant]
CA 1049335A · 1979 [cited by applicant]
CN 114539887A · 2022 [cited by applicant]
EP 0076515A1 · 1983 [cited by applicant]
EP 0361677B2 · 1993 [cited by applicant]
EP 0815743A2 · 1998 [cited by applicant]
EP 1371410A1 · 2003 [cited by applicant]
EP 1797946A2 · 2007 [cited by applicant]
RU 2351364C2 · 2009 [cited by applicant]
WO 9901214A1 · 1999 [cited by applicant]
WO 0105926A1 · 2001 [cited by applicant]
WO 03013538A1 · 2003 [cited by applicant]
WO 2004064971A2 · 2004 [cited by applicant]
WO 2006024411A2 · 2006 [cited by applicant]
WO 2007135583A2 · 2007 [cited by applicant]
WO 2008118133A2 · 2008 [cited by applicant]
WO 2009098226A1 · 2009 [cited by applicant]
WO 2011041395A2 · 2011 [cited by applicant]
WO 2015091877A1 · 2015 [cited by applicant]
WO 2016071151A1 · 2016 [cited by applicant]
WO 2017023830A1 · 2017 [cited by applicant]
WO WO2020092568A2 · 2020 [cited by examiner]
WO 2020195132A1 · 2020 [cited by applicant]
Jardine. (2022). Amino-functionalized polysaccharide derivatives: Synthesis, properties and application. Current Research in Green and Sustainable Chemistry 5, 100309. [cited by applicant]
Gasparini et al. (2020). Quantification of residual perfume by Py-GC-MS in fragrance encapsulate polymeric materials intended for biodegradation tests. Molecules, 25, 718. [cited by applicant]
Larson et al. (2017). Bulky polar additives that greatly reduce the viscosity of concentrated solutions of therapeutic monoclonal antibodies. Journal of Pharmaceutical Sciences, 106, 1211-1217. [cited by applicant]
Guo et al. (2012). Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies. Pharm Res, 3102-3109. [cited by applicant]
Kumar et al. (2017). Viscosity-reducing bulky-salt excipients prevent gelation of protein, but not carbohydrate, solutions. Appl Biochem Biotechnol, 1491-1496. [cited by applicant]
Wang et al. (2021). Hofmeister effect on the viscosity properties of gelatin in dilute solutions. Colloids and Surfaces B: Biointerfaces, 206, 111944. [cited by applicant]
OECD 301D method (OECD 1992, Test No. 301 Ready Biodegradability, OECD Guidelines for the Testing of Chemicals, Section 3, OECD Publishing, Paris, https://doi.org/10.1787/9789264070349-en. [cited by applicant]
Thakore et al. (2001). “Studies on biodegradability, morphology and thermo-mechanical properties of LDPE/modified starch blends.” European polymer journal, 37(1), 151-160. [cited by applicant]
Adhesives Magazine (2016). Sartomer: Acrylate Oliogmer. Available at: https://www.adhesivesmag.com/articles/94922-sartomer-acrylate-oligomer. [cited by applicant]
Leung et al. (2017). Enteric coating of micron-size drug particles through a Wurster fluid-bed process. Powder Technology, 317, 247-252. [cited by applicant]
Luo et al. (2014). Zein-based micro-and nano-particles for drug and nutrient delivery: A review. Journal of Applied Polymer Science, 131(16): 40696, 1-12. [cited by applicant]
Silverajah et al. (2012). Mechanical, thermal and morphological properties of poly (lactic acid)/epoxidized palm olein blend. Molecules, 17(10), 11729-11747. [cited by applicant]
Tmakova et al. (2015). Plant-derived surfactants as an alternative to synthetic surfactants: surface and antioxidant activities. Chemical Papers, 70(2), 188-196. [cited by applicant]
Werner et al. (2007). Air-suspension particle coating in the food industry: Part I—State of the art. Powder Technology, 171(1), 25-33. [cited by applicant]
English language abstract for WO 2009098226 A1 (2009). [cited by applicant]
English language abstract for WO 2020195132 A1 (2020). [cited by applicant]
http://polymerdatabase.com/polymer%20physics/sigma.html downloaded on Apr. 29, 2022. [cited by applicant]
Ko et al., “Characterization of hydrophilic-hydrophobic polymeric surfaces by contact angle measurements”, Journal of Colloid and Interface Science, vol. 82(1) (1981). [cited by applicant]
Cited By (1)
US 12,723,125